RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes.

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes.

Add to Collection
2011 Sep Others Fist_Author_Year_PM

Full Author : ['Perez-Monteverde, A', 'Seck, T', 'Xu, L', 'Lee, M A', 'Sisk, C M', 'Williams-Herman, D E', 'Engel, S S', 'Kaufman, K D', 'Goldstein, B J']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2011
Cited by : Not Available

AIM: The efficacy and safety of sitagliptin (SITA) monotherapy and SITA/metformin (MET) vs. pioglitazone (PIO) were assessed in patients with type 2 diabetes and moderate-to-severe hyperglycaemia (A1C = 7.5-12.0%). METHODS: In an initial 12-week phase (Ph.....

Keywords : ["metformin vs pioglitazone", "type diabetes", "fixeddose combination", "drugnaive patient", "sitagliptin", "sitagliptin", "safety", "efficacy"]